Learn more about our recent funding announcementOBIO’s’ Early Adopter Health Network (EAHN™)
EAHN™ matches Canadian health technology companies with a national network of healthcare organizations to evaluate technologies in the real-world setting and to facilitate their broad adoption into the health system.
Proudly supporting partnerships between Canadian health technology companies and health system.
OBIO®, through EAHN™, supports health technology companies and healthcare organizations to evaluate technologies in the real-world setting, widely disseminate technologies that prove value-producing, and create showcase sites to demonstrate successful Canadian technologies to the global market. Financial support is available for both the company and healthcare organization during the evaluation.
The EAHN™ program facilitates industry-driven partnerships with healthcare organizations that help Canada’s health system improve patient care, provider satisfaction and system efficiency.
Canada is home to some of the world’s most innovative companies with a strong history of developing state of the art healthcare solutions.
EAHN™ works with national and regional innovation partners in the health sciences ecosystem to assist companies and health partners with resources, adoption strategies and program support.
Learn more about the Canadian companies and innovative health technologies undergoing evaluation through EAHN™.
Industry-driven partnerships that help Canada’s health system improve patient care, provider satisfaction and system efficiency.
Canada is home to some of the world’s most innovative companies with a strong history of developing state of the art healthcare solutions.
That is why OBIO® EAHN™ is driving innovation into the Ontario health system through an end-to-end process, extending from technology evaluation to adoption.
Advancing Canada’s competitive edge in health technology innovation and commercialization.
Through collaborative partnerships with industry, the investment community, academia, patients, and government, the Ontario Bioscience Innovation Organization (OBIO®) seeks to cultivate the market conditions for a thriving biosciences industry. EAHN™, OBIO’s newest offering, partners Canadian companies developing health technologies that are ready for adoption with Ontario health organizations.
Get in touch
